FindTrial
Sign In

Ayurvedic intervention in COVID-19 patients

An Open Label Single arm Clinical Trial on the effectiveness of Ayurveda interventions in the management of Hospitalized Mild to moderate COVID-19 patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026922
Enrollment
30
Registered
2020-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Ayurveda Drug intervention for 10 days: Vyaghryadi kwatha 50 ml twice a day Samshamani Vati 2 tablets 500 mg each twice daily Ashwagandha (Withania somniferum) 2gm in powdered fo

Sponsors

State plan management Unit National Health Mission Uttar Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mild to Moderate COVID-19 Positive cases. Patients with mild co-morbidities. Patients willing to give informed consent.

Exclusion criteria

Exclusion criteria: Severe type of COVID-19 Positive cases. Patients with severe co-morbidities. Patients with Severe Difficulty in breathing. Patients willing to give informed consent.

Design outcomes

Primary

MeasureTime frame
To assess role of Ayurvedic Drugs on the immunological markers in Covid 19 patients Timepoint: 10 days—

Secondary

MeasureTime frame
to validate the effect of Ayurveda druug intervention on Biochemical markers and Involved cytokines in COVID-19Timepoint: 10 days—

Countries

India

Contacts

Public ContactAdil Rais

Lokbandhu Rajnarayan Combined Hospital

adil.rais13@gmail.com7060272769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026